In the United States, the median value of enterprise value to earnings before interest, tax, depreciation and amortization (EV/EBITDA) in the health and pharmaceuticals sector as of 2024 was a multiple of approximately 15x. Companies operating in the healthcare products industries saw the highest valuation multiple with EV/EBITDA ratio of 21.5x in 2024, up from 19.1x in 2023.
Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2024, by industry
Values are as of January each year. A total of 1,326 companies were included in the calculation for 2024, 1,236 for 2023, 1,427 for 2022, 1,399 for 2021, 1,305 for 2020 and 1,230 for 2019.Â
Enterprise value = Market value of equity + Market value of debt - Cash. EBITDA = Estimated by adding depreciation and amortization back to operating income (EBIT). Only positive EBITDA companies.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Leonard N. Stern School of Business. (January 5, 2024). Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2024, by industry [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business. "Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2024, by industry." Chart. January 5, 2024. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business. (2024). Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2024, by industry. Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business. "Average Ev/Ebitda Multiples in The Health and Pharmaceuticals Sector in The United States from 2019 to 2024, by Industry." Statista, Statista Inc., 5 Jan 2024, https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
Leonard N. Stern School of Business, Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2024, by industry Statista, https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/ (last visited December 22, 2024)
Average EV/EBITDA multiples in the health and pharmaceuticals sector in the United States from 2019 to 2024, by industry [Graph], Leonard N. Stern School of Business, January 5, 2024. [Online]. Available: https://www.statista.com/statistics/1030072/enterprise-value-to-ebitda-in-the-health-and-pharmaceuticals-sector-in-united-states/
